Category: JCN Newswire

TOKYO, Mar 17, 2026 - (JCN Newswire via SeaPRwire.com) - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) served as a category sponsor (awards ceremonies) for the LIGA.i Blind Soccer Top League 2025 (organized by the NPO Japan Blind Football Association, JBFA), held from August 2, 2025, to February 23, 2026.TANAKA has been a partner of the JBFA and a sponsor of the Japan Blind Football Women’s National Team since 2017, supporting their activities to raise awareness of and promote blind football. As a category sponsor of the tournament, TANAKA sponsored the operation of the awards ceremonies with the aim of contributing to the further development of blind football, and provided medals, commemorative items, and trophies to be awarded to teams and players.The LIGA.i Blind Soccer Top League was established in 2022, and this year marked its fourth tournament. The LIGA.i Blind Soccer Top League 2025 kicked off with the first round in August 2025, proceeded through the second round on December 7, and concluded with the final round on February 23, 2026, at Yokohama Budokan (Yokohama City, Kanagawa Prefecture). After a series of exciting matches, free bird mejirodai won the championship and buen cambio yokohama finished as runner-up.At the awards ceremony held at the venue after the matches concluded, the Most Valuable Player award was presented to Yuzuki Sonobe (free bird mejirodai). The Top Scorer award was shared by four players: Ryo Kawamura (Shinagawa CC Papelecial), Yuki Saito (buen cambio yokohama), Sodai Hongo (free bird mejirodai), and Yuzuki Sonobe (free bird mejirodai). The special award, the TANAKA Great Effort Award, was presented to Shunsuke Nakamura (buen cambio yokohama). The final round also featured a full day of events, including visitor participation activities, greeting events with mascot characters, and cheerleading performances, and attracted a record 1,420 visitors, the highest in LIGA.i history (according to the organizer).The matchesTournament OverviewTournament NameLIGA.i Blind Soccer Top League 2025OrganizerNPO Japan Blind Football AssociationDatesAugust 2, 2025, to February 23, 2026Venue・Shinagawa LIGA.i Blind Soccer Top League 2025 Round 1: August 2; Shinagawa General Gymnasium (Shinagawa-ku, Tokyo)・LIGA.i Blind Soccer Top League 2025 Round 2: December 7; Fukushi Enterprise Sumida Field (Sumida-ku, Tokyo)・KPMG LIGA.i Blind Soccer Top League 2025 Round 3: February 23, 2026; Yokohama Budokan (Yokohama City, Kanagawa)Special Event Websitehttps://liga-i.b-soccer.jp/ Tournament ResultsMatch Results on February 23 ・Match 1: ・Match 2:buen cambio yokohama 2–1 Saitama T.Wingsfree bird mejirodai 1–2 Shinagawa CC PapelecialFinal Standings:Champion: free bird mejirodai2nd Place: buen cambio yokohama3rd Place: Shinagawa CC Papelecial4th Place: Saitama T.WingsContributions by TANAKATeam Awards・Champion Team: League Cup (Championship Silver Plate with Tournament Logo)・Champion Team Players: Medals (with Tournament Logo)Individual Awards・Most Valuable Player: Commemorative Item (Plaque with Tournament Logo)・Top Scorer: Commemorative Item (Plaque with Tournament Logo)・TANAKA Great Effort Award: Commemorative Item (Crystal Trophy with 1/25 oz. Platinum Vienna Harmony Coin and Tournament Logo)・Player of the Match: Commemorative Item (Crystal Trophy with Tournament Logo)*Only the Player of the Match will be awarded in each of the six matchesMeaning Behind the League Name “LIGA.i”“LIGA.i” represents the hope to improve “Intensity,” “Influence,” and “Integrity” to enhance the value of blind football and create a more inclusive society. Along with this desire to change today’s society, the fact that everyone involved in “LIGA.i” has the freedom to create their own unique “i” generates diversity, allowing every single person to take the initiative in building the league.*With the establishment of the new league, LIGA.i, in 2022, blind football now has a three-tournament system consisting of the Japan Championship, in which club teams from across the country can participate; the Regional League, which is held in four areas across the country; and the Top League, in which only teams that meet certain eligibility conditions can participate.About TANAKASince its foundation in 1885, TANAKA has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,591 employees, the group’s consolidated net sales for the fiscal year ended December 2024 were 846.9 billion yen.TANAKA PRECIOUS METAL GROUP Co., Ltd.TANAKA Corporate Websitehttps://www.tanaka.co.jp/english/Press inquiriesTANAKA PRECIOUS METAL GROUP Co., Ltd.https://www.tanaka.co.jp/support/req/other_contact_e/index.htmlPress Release: https://www.acnnewswire.com/docs/files/20260317.pdf Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 17, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced the establishment of Eisai Global Capability Centre (EGCC) within Eisai Knowledge Centre, India, in Visakhapatnam (Vizag), Andhra Pradesh, India. The opening ceremony was held today, marking the commencement of its operation. The Centre serves as Eisai’s information technology hub.(Standing from left to right) Muneo Takahashi, Consul General of Japan in Chennai (South India Jurisdiction); KeisukeNaito, Eisai COO and Chief Growth Officer; Yumiko Aoyagi, First Secretary, Embassy of Japan in India; VijayaKrishnan, IAS District Director, Anakapalli.)The establishment of EGCC represents a core initiative of Eisai Group’s long-term IT strategy. By integrating external expertise and cutting-edge technologies, the EGCC insources the design and operation of internal information technology services. This, in turn, enables delivery of standardized high quality information technology services in a secure environment, strongly supporting Eisai Group’s global business operations. With the EGCC taking the lead in global IT functions, Eisai will transition its organizational structure, allowing regional IT functions to focus more on strategic business transformation aligning with their region-specific operations.In its initial phase, the EGCC will focus primarily on standardizing global IT infrastructure operations. The Centre plans to gradually expand its scope to include cybersecurity, data & analytics, and operational applications, in response to business needs.Eisai established “Eisai Knowledge Centre, India, in Andhra Pradesh in 2009. Since then the facility has served as a core operational hub for our global production and process research, while also contributing to employment creation in the local area. Andhra Pradesh is currently spearheading initiatives to establish a “New IT City” by designating Special Economic Zone (SEZ), attracting data centers and AI hubs, and aiming to create 300,000 IT jobs. By establishing the EGCC within the “Eisai Knowledge Centre, India”, we aim to recruit and nurture excellent global IT human resource who resonates with our “human health care (hhc)” concept. Through long-term employment and career development opportunities, we will contribute to the development of the local IT ecosystem and economic prosperity.Media Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120Photographs of Inside and Outside of the Global Capability Center Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

・Entire process completed in just 8 weeks, including AI development, UAV installation, and flight・Strengthened collaboration with Shield AI to accelerate mission autonomy developed in JapanTOKYO, Mar 17, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has successfully conducted flight demonstrations of AI-powered mission autonomy developed for use in unmanned aerial vehicles (UAVs) by leveraging an AI development environment through Hivemind Enterprise provided by US company Shield AI Inc. (hereinafter SAI Inc.). The entire process, from AI development to UAV installation and flight, was completed in just eight weeks.In previous development efforts, MHI built and maintained an environment that leveraged multiple open-source products to perform in-house coding, AI training, simulation evaluation, and Hardware-in-the-Loop (HIL) testing(Note), which required significant effort. In contrast, by leveraging Hivemind Enterprise for this project, greater focus could be placed on developing mission autonomy.Mission autonomy development for this flight demonstration began in September 2025. Flight demonstrations were conducted on November 7 at the test field in Inashiki District, Ibaraki Prefecture, and on December 18 at the test field in Ota City, Gunma Prefecture. Specifically, the AI was completed following prior AI training, simulation evaluation, and HIL testing, then installed in the ARMD (Affordable Rapid-prototyping Mitsubishi-Drone initiative) UAV, which flew through the skies, completing successful flight demonstrations.Mission autonomy is a critical technology shaping Japan's UAV operations, and MHI considers domestic production essential. Building on the rapid development of this Japan-made mission autonomy system, MHI and SAI will strengthen collaboration and further accelerate mission autonomy development.Leveraging the latest AI technology to address various challenges through UAV, MHI strives to help realize a safe, secure, and comfortable society.(Note) A method for verifying the operation of hardware before installationARMD SpecificationsDimensions: Overall length 2.5 m, main wingspan 2.5 mTakeoff weight: 20 kgPower source: Engine (a) ARMD-01(Unit 1) (b) ARMD-02(Unit 2)About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Japan, Mar 17, 2026 - (JCN Newswire via SeaPRwire.com) - The University of Tokyo (UTokyo) and NEC Corporation (NEC) have concluded an strategic collaboration agreement and will establish a new NEC-UTokyo Lab. This initiative is based on the "Future Synergy with AI: Toward Trustworthy Social Implementation" program that promotes a prosperous society where people and AI can succeed together. The NEC-UTokyo Lab will host joint activities under this agreement, driving three integrated initiatives: exploring issues through discussions with diverse stakeholders, advancing social implementation through collaborative programs, and fostering talent development.This agreement advances efforts to develop an AI-native society, including thought leadership (*1) activities and actual implementation. Both parties will engage not only in technological development but also initiatives that include legal reforms, the formation of ethical and social norms, and the deepening of interdisciplinary research. Through these efforts, both parties will promote a new vision for society based on safety and security within an AI-native society that contributes to a sustainable future.Overview of the collaboration between UTokyo and NECBackgroundIn recent years, AI has been rapidly evolving and is poised to significantly transform society and industry. At the same time, diverse challenges surrounding AI utilization have become apparent, including ethics, social acceptability, and the relationship between people and AI. During this transition to an AI-native society, it is essential to move beyond isolated technological development and partial institutional reforms. Instead, a framework is needed for the design and implementation of a vision for the future that encompasses the whole of society.UTokyo and NEC will comprehensively advance efforts under this agreement, encompassing legal framework development, technological innovation, human resource cultivation, and concrete implementation, guided by the vision, "Future Synergy with AI: Toward Trustworthy Social Implementation." Concurrently, the organizations aim to strengthen Japan's industrial competitiveness and to resolve digital divides between regions.Under this agreement, by combining UTokyo's advanced knowledge with NEC's cutting-edge technologies, the organizations aim to become a powerful driving force for creating a prosperous society, where people and AI succeed together.NEC-UTokyo Lab Initiatives1. Creating platforms for leaders and experts to identify challenges and explore resolutionsBy bringing together diverse stakeholders, including industry leaders and legal experts, and integrating the knowledge of the University of Tokyo and NEC, the NEC-UTokyo Lab will explore questions centered on coexistence with AI from multiple perspectives. Through this activity, the lab will propose visions for Japan and the world's future alongside possible solutions for critical social challenges. Moreover, in addition to sharing these insights with society, the lab will seek to promote research and talent development within its Social Collaboration Program.2. Accelerating Social Implementation through the Social Collaboration ProgramThe NEC-UTokyo Lab’s Social Collaboration Program will be dedicated to designing a future where people and AI successfully coexist as new technologies grow throughout society.The boundaries between digital spaces based on data and AI and physical spaces where people live are gradually blurring. One example of this is the emergence of an agent economy where AI agents are becoming the primary actors in economic activities.To successfully promote these new social and economic systems, NEC and UTokyo will collaborate to explore the ideal forms of social systems, ethics, and legal frameworks, and promote their implementation. For example, NEC positions "automated negotiation AI" (*2), which facilitates optimal consensus-building among multiple AI agents, as a key technology underpinning the agent economy. Furthermore, the organizations will expand their research themes in the future and accelerate the implementation of AI solutions to build a sustainable and trustworthy AI-native society.3. Cultivating Next-Generation Leaders to Drive the AI-Native SocietyThe NEC-UTokyo Lab will work to cultivate talents capable of leading the realization of a prosperous society where people and AI succeed together. As part of this effort, the lab plans to prepare next-generation leaders through long-term internships and design education programs at the newly established "UTokyo College of Design" (*3).The lab will also promote flexible personnel exchanges where students and researchers from both UTokyo and NEC can interact. This will further strengthen organic collaboration and accelerate efforts from exploring questions to societal implementation of concepts and technologies.Comments from Both Parties"NEC, with its in-house developed generative AI technology and extensive AI implementation experience across various fields, and the University of Tokyo, with its advanced and broad expertise, will take the lead in creating a dialogue platform for diverse stakeholders to identify future societal challenges. We expect this strategic collaboration to become a platform for advancing AI implementation that contributes to building a better AI-native society and for cultivating the next generation of leaders who will drive this forward."Teruo Fujii, President, The University of Tokyo"We are delighted to establish the NEC-UTokyo Lab through this industry strategic collaboration agreement with the University of Tokyo. As AI fundamentally reshapes societal foundations, Japan's growth and industrial competitiveness now depend not only on technology but also on reliable, well-governed societal implementation. By combining the diverse knowledge of the University of Tokyo with NEC's implementation capabilities, we will advance the establishment of ‘trustworthy AI’ and promote its practical application throughout the world."Takayuki Morita, President and CEO, NEC Corporation(1) Thought Leadership: Leading discussions and direction in a specific field with deep expertise and unique insights, presenting a vision for the future and solutions to challenges. https://www.i-ise.com/en/index.html(2) Automatic Negotiation AI: NEC's proprietary AI technology that automates various adjustments and negotiations traditionally performed by humans.(3) UTokyo College of DesignAbout NECThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.For more information, please visit https://www.nec.com, and follow us on LinkedIn and YouTube. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy Japan Ltd. has been recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) under the recognition program, jointly administered by Japan’s Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi (Japan Health Council).Since 2023, the company has been recognized in the Small and Medium‑Sized Enterprise Category for three consecutive years. In 2026, Hitachi Energy in Japan was recognized for the first time in the Large Enterprise Category, reflecting its workforce growth. Organizations certified in this category are expected to lead by example, extending health and productivity management beyond their own operations to group companies, business partners, local communities, customers, and employees’ familiesPeople‑Centric HSE as a Foundation for the Energy TransitionAt Hitachi Energy, we promote “Health and Productivity Management”—activities designed to maintain and enhance employee health—guided by the Hitachi Group Safety and Health Policy, whose core principle is that safety and health always come first, and our global HSE*1 policy, which focuses on improving health and well‑being in the workplace.*1 Health, Safety, and Environment.With people at the heart of everything we do, Hitachi Energy views health and productivity management as a management foundation that underpins corporate value and social trust. By fostering a safe and healthy work environment through shared responsibility and continuous improvement, the company reinforces its role in advancing the energy transition and shaping a sustainable energy future for all.About the Health & Productivity Management Outstanding Organization Recognition ProgramThe Health & Productivity Management Outstanding Organization Recognition Program is a program established by Japan’s Ministry of Economy, Trade and Industry (METI) in fiscal year 2016. The program highlights large enterprises and small and medium‑sized enterprises that are implementing particularly excellent health and productivity management, and aims to develop an environment in which such organizations can gain enhanced recognition from employees, job seekers, related companies, and financial institutions. Marking its 10th year, the 2026 program recognized 3,765 organizations in the Large Enterprise Category and 23,085 organizations in the Small and Medium‑Sized Enterprise Category.ReferenceNippon Kenko Kaigi (Japan Health Council) – Official Website (Japanese)ACTION! Health & Productivity Management – Portal SiteAbout Hitachi EnergyHitachi Energy is a global technology leader in electrification, powering a sustainable energy future with innovative power grid technologies with digital at the core. Over three billion people depend on our technologies to power their daily lives. With over a century in pioneering mission-critical technologies like high-voltage, transformers, automation, and power electronics, we are addressing the most urgent energy challenge of our time – balancing soaring electricity demand, while decarbonizing the power system. With an unparalleled installed base in over 140 countries, we co-create and build long-term partnerships across the utility, industry, transportation, data centers, and infrastructure sectors. Headquartered in Switzerland, we employ over 50,000 people in 60 countries and generate revenues of around $16 billion USD.https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergyAbout Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Kawasaki and Tokyo, Japan, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Japan Limited and Teikyo University Hospital today announced the start of a joint proof of concept aimed at strengthening regional medical collaboration. The initiative, which commenced on March 16, focuses on developing new information analysis and patient management mechanisms utilizing medical administration systems and electronic health record data. This will facilitate the prompt admittance of severely ill patients requiring hospitalization or surgery and a smooth transition back to primary care after discharge.This joint experiment will implement the following initiatives for Teikyo University Hospital's regional medical collaboration operations:1. Digitalization of Patient Workflow from Referral Acceptance to Discharge CoordinationBy introducing AI-OCR and electronic paper for referral reception and discharge coordination, information from outside the hospital will be digitized. This will be seamlessly integrated with electronic health records and regional medical collaboration information systems, aiming to eliminate duplicate data entry and improve overall operational efficiency.2. Verification of the Health Care Management Platform for Data-Driven Strategic Patient AcquisitionBased on data from medical accounting systems and electronic health records, Health Care Management Platform, an offering under Fujitsu Limited's Uvance business model which addresses societal challenges, will be used to visualize and analyze trends in referred patients and collaborating facilities in a timely manner. This will enable the identification of facilities where collaboration should be strengthened, and actual visits to these facilities will be conducted to enhance regional collaboration. Visit records and results will be registered and accumulated in Salesforce's Agentforce 360 Platform, aiming to utilize this information for analyzing referral performance and formulating strategies that comprehensively address the needs of collaborating facilities.Figure: Patient workflow in regional medical collaboration and a joint proof of conceptThrough this initiative, Teikyo University Hospital aims to reduce the administrative workload of its Medical Collaboration Office, which handles regional collaboration tasks, by 30%, while contributing to the provision of high-quality and prompt medical care and the optimization of medical resources for patients.Moving forward, both parties will expand the scope of integration between this system and electronic health records to centrally manage the patient workflow, including treatment processes after referral acceptance. This will contribute to providing medical care to patients at more appropriate times and supporting decision-making for healthcare professionals, thereby improving hospital management and fostering regional medical collaboration.Fujitsu Japan will leverage the insights from this joint experiment to enhance accuracy and add new functionalities to its offerings, supporting Teikyo University Hospital's digital transformation (DX) and the promotion of digital hospitals. Furthermore, under Uvance, Fujitsu Japan will drive the transformation of medical practice workflows through data and AI, advancing the establishment of a sustainable healthcare delivery system.Teikyo University Hospital will systematize this mechanism as a model for realizing a data-driven regional healthcare system and promote its expansion to other medical institutions and regions. Through this initiative, the hospital also aims to further enhance the role and value of its Medical Collaboration Office, which serves as the hospital's public face, and build a foundation for the office to function as a hub for regional medical care, moving beyond its traditional role of handling referral reception and coordination.BackgroundJapanese healthcare faces a challenging management environment due to a declining birthrate, an aging population, and rising material costs, while medical needs are becoming increasingly complex due to advancements in medical technology. To ensure sustainable healthcare, it is essential to strengthen collaboration between primary care physicians and specialists, ensuring patients are referred at appropriate times, receive advanced treatment, and are then referred back to their primary care physicians for ongoing care. This kind of regional medical collaboration is essential.The Japanese government is also promoting medical DX and functional differentiation and collaboration within regions, establishing evaluations and incentives in the fiscal year 2026 medical fee revision.As a specialized hospital in the Itabashi Ward region, Teikyo University Hospital accepts over 30,000 referred patients annually and has actively promoted regional collaboration through continuous lectures and visits to medical institutions. Regarding referred patient acceptance, the hospital receives approximately 200 calls daily from patients and medical institutions, utilizing up to eight lines at a time. A key challenge has been the time and burden placed on reception staff to coordinate referred patient acceptance, especially for urgent referrals and transfer requests from other medical institutions, often requiring consultation with doctors, leading to waiting times for outpatient appointments and hospitalization.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its first set of full-year results as a Hong Kong listed company for the 12 months ended 31 December 2025.- New business sales were up 25 per cent to US$2.446 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) was US$1.476 billion, with year-on-year growth of 18 per cent.- Operating profit after tax was up five per cent to US$499 million with positive contributions from each of the company’s four geographic reporting segments – Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$166 million is a record IFRS 17 result and for the second consecutive year, FWD Group was operating cash flow positive as at 31 December 2025. Leverage ratio reduced to 21.3 per cent approaching the company’s target range of 15-20 per cent.- Significantly increased important indicators of shareholder value creation, with comprehensive tangible equity (CTE) up 18 per cent to US$8.72 billion compared to 31 December 2024 and Group embedded value (EV) up 19 per cent year-on-year to US$6.85 billion. A strong capital position was maintained with a 265 per cent solvency ratio^.- In December 2025, FWD Group was added to the Hang Seng Composite Index and the eligible securities list for the Stock Connect programme, where Mainland Chinese investors connect via the Shanghai Stock Exchange and Shenzhen Stock Exchange with Hong Kong market opportunities via a southbound trading mechanism. FWD Group was also included in the MSCI Hong Kong Small Cap Index in February 2026.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “2025 was a stand-out year for FWD Group. We successfully executed our customer-led strategy, underpinned by our digitally enabled business model. Record financial results were achieved. And of course, we began trading as a publicly listed company, following our July 2025 initial public offering. This fulfilled a long-held objective to ensure FWD Group has full capital market access, as a solid foundation for our future development and growth.”The strong 2025 results were driven by organic growth across most of the 10 Asian markets where FWD Group operates, with a particularly outstanding performance in the Hong Kong SAR & Macau SAR segment.A solid performance was posted in Japan, in a year where FWD began to diversify beyond its successful protection business into the retirement and savings segment, with its first offering – a yen-denominated single premium variable annuity product.As an established market leader in Thailand, FWD remains well positioned to grow quality new business in future, despite headwinds from a lower rate environment which impacted 2025 results, in addition to the 2024 exit from underwriting new business in the corporate care segment.Excellent growth was delivered in the Emerging Markets segment – which is comprised of five of the rest of FWD Group’s Southeast Asian markets – consistent with the longer-term demographic, wealth creation, and digital adoption trends in this region.“With 2026 already underway, we remain firmly focused on executing our strategy as we build for the future – operating with customers at the heart of everything we do in high-growth Asian markets, with a focus on long-term sustainability and profitability,” added Huynh Thanh Phong.About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves more than 38 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828.For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings LimitedThe results are for the 12 months ended 31 December 2025 and are compared to the same period in 2024.Group LCSM cover ratio, group embedded value, comprehensive tangible equity values are December 2025 balances/ratios and growth rates are represented accordingly.Growth rates are represented on a constant exchange rate (CER) basis, unless otherwise stated.Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Comprehensive tangible equity is calculated as total equity of the Group attributable to shareholders of the Company plus contractual service margin (net of tax and non-controlling interests), minus intangible assets (net of non-controlling interests).* Actual exchange rate basis ^ Prescribed capital requirement (PCR) basis Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

WAKASHIO MARUTOKYO, Mar 13, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Shipbuilding Co., Ltd., a part of Mitsubishi Heavy Industries (MHI) Group, today completed the handover of WAKASHIO MARU, a training ship for National Institute of Technology, Toyama College (NIT, Toyama College). The handover followed a christening and launch ceremony for the ship in October 2025 at the Enoura Plant of MHI's Shimonoseki Shipyard & Machinery Works in Yamaguchi Prefecture, and the completion of interior work and sea trials.This is the fifth generation training ship for NIT, Toyama College, and the first replacement ship for the school in 31 years since 1995. It is the first ship Mitsubishi Shipbuilding has built for the school. The ship will be utilized for navigation practice, operations, and ocean-related research, along with various other educational and community contribution activities to develop marine sector human resources, contribute to local communities, and disseminate maritime-related messages. The ship is also equipped to provide a range of disaster support functions, including transporting relief supplies and providing housing facilities in the event of a natural disaster.Going forward, Mitsubishi Shipbuilding will continue to support its customers and the advancement of society by leveraging its synergy with MHI Group to build ships that embody even more advanced development and design for the maritime field, and contribute to the training of next-generation maritime officers, and oceanographic surveys.Main Specifications of the WAKASHIO MARUOwnerNational Institute of Technology, Toyama College(NIT, Toyama College)LOA56.48 metersBeam10.60 metersDepth5.95 metersGross tonnage389 tonnesCapacityApprox. 60 personsService speed12.5 knotsAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 13, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) today announced its strategic intent to work toward the introduction of a 10-megawatt (MW) class centrifugal chiller for next-generation AI data centers in the North American market, targeting industrial-grade AI computing infrastructure. The company plans to obtain U.S. safety and regulatory certification, including UL, potentially as early as 2026, with commercial availability targeted thereafter.As demand for large-scale AI computing accelerates globally, data center operators are increasingly prioritizing proven reliability, energy efficiency, and water sustainability over experimental technologies. Leveraging decades of industrial experience, MHI is positioning its centrifugal chiller solution as a potential standardized cooling platform for gigawatt-class AI data centers, where operational track record is a critical decision factor.Proven Industrial Leadership Delivering Outstanding Energy and Water EfficiencyMHI's centrifugal chillers are backed by an extensive track record across industrial and mission-critical applications, supported by a leading approximately 60% domestic market share in Japan(*1). This proven performance base provides a strong foundation for data center operators seeking dependable cooling infrastructure for continuous, high load operation.Key features of the solution include:High efficiency centrifugal chiller design utilizing an in-house developed compressor, optimized through a single-compressor configuration to achieve superior part-load and full-load performance.Integrated plant-level control using MHI's proprietary Control System and self-designed Modular Chiller Plant (MCP) architecture, enabling effective utilization of free-cooling operation modes and improved Power Usage Effectiveness (PUE).Low-water-consumption cooling configurations using dry coolers to address growing concerns around water scarcity and Water Usage Effectiveness (WUE) in large-scale data centers.A system design philosophy that emphasizes operational stability, repeatability, and long-term efficiency, rather than reliance on unproven technologies.Together, these features are expected to facilitate both energy efficiency and environmental sustainability, while maintaining the robustness required for AI workloads operating at unprecedented scale.Designed for Emerging AI Data Center ArchitecturesThe newly announced 10MW-class chiller is optimally designed with the objective of aligning with emerging reference architectures for large-scale AI computing facilities, which demand higher cooling capacity, increased redundancy, and standardized deployment models.By addressing the cooling requirements of gigawatt-class AI data centers, MHI's solution aims to support the evolution of data centers from traditional IT facilities into fully integrated AI data centers, where cooling infrastructure plays a direct role in enabling computing performance, uptime, and total cost optimization.Mitsubishi Heavy Industries Group is dedicated to delivering more sustainable and reliable solutions to data centers by combining decarbonized power generation, reliable power distribution, high efficiency cooling systems and Integrated Digital Solutions. We seek to empower our customers through the complete lifecycle from design phase to post deployment with actionable insights, solutions and services. This initiative represents a key step in MHI's broader global strategy to expand its data center cooling portfolio, with a strong focus on high-density AI workloads, sustainability, and industrial-grade reliability.(*1) This represents MHI Group's share of the centrifugal chiller market in Japan.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

From a joyful Raya musical to new and improved festive recipes, Spritzer Sparkling inspires Malaysians to embrace fresh new ideas alongside tradition to elevate their Raya celebrationsSpritzer Sparkling’s 2026 Raya musical brand film “Samting-Samting”, stars Fimie Don and Wani Kayrie as a married couple, and Elliza Razak as Mak Ngah.TAIPING, Malaysia, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - Hari Raya Aidilfitri in the month of Syawal is a cherished time of celebration and time-honoured family traditions, with the kitchen often becoming the heart of the festivities. As families balik kampung and fill their homes with the joy and warmth of festive cooking this year, Spritzer Sparkling invites Malaysians to celebrate Raya with a modern twist through its ‘Serikan Raya, Sparkling-kan Suasana’ campaign, showcasing the versatility of the product in boosting the creativity and flair of beloved Raya dishes.For the first time, Spritzer Sparkling is expanding beyond its well-loved role as a beverage mixer with a fresh take on festive cooking through the multipurpose use of its naturally refreshing sparkling water in your favourite recipes. Spritzer Sparkling transforms five traditional must-have Raya dishes into festive showstoppers, bringing a new dimension of taste with its lively carbonation enhancing the texture, crispiness, and tenderness of the dishes. These favourites include Cucur Udang Crispy, Rendang Tok Melting, and Roti Jala with Kari Ayam, alongside refreshing drinks like Bunga Longan Sparkling and Limau Selasih Pudina Sparkling.This Raya, add a little ‘Samting-Samting’ extra to your recipes for an exciting new twist on your favourite festive dishes with Spritzer SparklingEach recipe showcases how the natural bubbles from Spritzer Sparkling help create lighter, crispier batters for a satisfying crunch and more tender, flavourful meats without changing the essence of the dishes. Whether it is giving your cucur udang a delightful crisp or tenderising your rendang meat and shortening the braising time, Spritzer Sparkling makes these traditional favourites even more enjoyable in simple, effortless ways.Shiao Chan, Head of Marketing at Spritzer, said, “Hari Raya Aidilfitri is a celebration deeply rooted in family traditions where food plays a central role in bringing people together. Through ‘Serikan Raya, Sparkling-kan Suasana’, we wanted to show Malaysians that tradition and heritage can co-exist and even be preserved through innovation and new perspectives. Spritzer Sparkling is not just a refreshing beverage for every season, but also a multi-faceted ingredient that can enhance festive dishes and drinks, creating memorable family moments in the kitchen and around the dining table.”A Musical Aidilfitri AwaitsBringing the Raya story to life is Spritzer’s musical film titled ‘Samting-Samting’, starring Fimie Don, Wani Kayrie and Elliza Razak. As the official Spritzer Sparkling brand ambassadors for Raya 2026, Fimie Don and Wani Kayrie, play a modern newlywed couple returning to the husband’s kampung for their first Raya together in the film that blends comedy, drama and music in an irresistibly Malaysian narrative.The young wife, Alia, takes on the kitchen with confidence, using her own modern approach to classic family dishes, prepared using her secret ingredient: Spritzer Sparkling. Mak Ngah, the family’s long-standing culinary matriarch, feels her role is being challenged and grows increasingly suspicious about Alia’s unusually delicious cooking, suspecting “Samting-Samting” is amiss. The story humorously unravels the “secret” behind Alia’s crowd-pleasing flavours, capturing family dynamics and celebrating new perspectives, shared discovery, and the warmth of intergenerational bonding.Home-cooks excited to try this new twist to classic recipes can check out the recipes for the featured dishes and beverages using Spritzer Sparkling as a game-changing ingredient on Spritzer’s Raya microsite here.Spritzer’s 2026 Raya campaign celebrates family traditions, playful generational dynamics in the kitchen, and creative festive cooking with Spritzer Sparkling.Also available on the website are the musical film, promotional details, meet-and-greet information with Fimie Don and Wani Kayrie, as well as gift-with-purchase promotions available at participating outlets nationwide.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottleFor more information, visit www.spritzer.com.myFor media inquiries please contact:Farah ShahrulAssociate Consultant, Narro CommunicationsE: farah@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 12, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. announced today that it has received an order from Chubu Electric Power Grid for Hitachi Energy’s EconiQⓇ 550 kilovolt (kV) sulfur hexafluoride (SF6)-free gas-insulated switchgear (GIS). This is set to be the world’s first project with 550 kV GIS*1 in which the entire equipment is SF₆-free.*1 In gas-insulated switchgear, all components are housed in fully sealed gas‑insulated compartments to reduce the substation size and protect the equipment from storms and other external interference.The EconiQ 550-kV GIS reduces CO2-equivalent emissions from the insulating gas by 99 percent compared with conventional SF₆‑insulated equipment. By delivering this technology, Hitachi will support Chubu Electric Power Grid in making Japan’s transmission network sustainable.For decades, SF6 gas has been widely used in power grids due to its excellent insulation properties and switching performance. However, it has a global warming potential 24,300 times higher than CO2 and remains in the atmosphere for more than 1,000 years if released. Many governments are now introducing regulations to phase out new SF6–based equipment to address climate change. Currently, Japan has no regulations on eliminating SF6 gas equipment.As Japan's electricity demand rises with increased electrification and the growth of data centers, the need to reinforce the grid while reducing greenhouse gas emissions becomes more urgent. SF6-free switchgear, such as Hitachi Energy's EconiQ technology, offers the solution to this twofold challenge – combining proven reliability and compact design with the lowest carbon footprint.In 2024, Chubu Electric Power Grid announced its policy on adopting SF₆‑free equipment for each voltage class and decided to introduce SF₆‑free GIS for voltages up to 77 kV, as well as SF₆‑free circuit breakers rated 275 kV and above. In line with the adoption policy defined in 2024, and with the aim of accelerating its efforts toward achieving carbon neutrality, Chubu Electric Power Grid has now chosen to deploy SF₆‑free equipment for 550 kV GIS. This equipment will be used in its backbone transmission network.Hitachi Energy launched its EconiQ high-voltage portfolio in 2021 to support the industry’s transition to SF6-free technologies. EconiQ products eliminate greenhouse gas emissions by replacing SF6 gas with an eco-efficient alternative while maintaining the same performance, size, safety, and reliability as conventional SF6-insulated equipment.About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com.About Hitachi EnergyHitachi Energy is a global technology leader in electrification, powering a sustainable energy future with innovative power grid technologies with digital at the core. Over three billion people depend on our technologies to power their daily lives. With over a century in pioneering mission-critical technologies like high-voltage, transformers, automation, and power electronics, we are addressing the most urgent energy challenge of our time – balancing soaring electricity demand, while decarbonizing the power system. With an unparalleled installed base in over 140 countries, we cocreate and build long-term partnerships across the utility, industry, transportation, data centers, and infrastructure sectors. Headquartered in Switzerland, we employ over 50,000 people in 60 countries and generate revenues of around $16 billion USD.https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergy Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Japan, Mar 12, 2026 - (JCN Newswire via SeaPRwire.com) - Honda Motor Co., Ltd. (Honda) today announced that it has made a decision to cancel the development and market launch of three EV (electric vehicle) models that had been planned for production in North America. This decision was made as part of the reassessment of the company’s automobile electrification strategy due to various factors including recent changes in the business environment.Consequently, Honda now expects to record losses in its consolidated financial results for the fiscal year ending March 2026, resulting in the revision of previously announced forecasts for the consolidated financial results for the fiscal year. More details and background of the decision and revisions made to the fiscal year forecasts are explained below.Automobile electrification strategy to date and changes in the business environmentSetting a goal to realize carbon neutrality for all products and corporate activities Honda is involved in by 2050, and due to a major policy change in the U.S. seeking to accelerate the transition to EVs, Honda undertook a major strategic shift toward the popularization of EVs based on its belief that EVs will be the optimal solution to realize carbon neutrality especially for small-size mobility products, including passenger cars, from a long-term perspective.Honda had been making steady progress in pursuit of EV adoption by leveraging its stable earnings base provided by existing gasoline and hybrid vehicle business based on technologies and know-how amassed through the development of hybrid models over many years, and motorcycle and financial services businesses with a solid customer base.However, the profitability of Honda automobile business is currently declining due primarily to 1) the unfavorable impact of changes in U.S. tariff policies on the gasoline and hybrid vehicle business and 2) a decline in the competitiveness of Honda products in Asia due to the impact of the allocation of more resources to EV development.In addition, the automobile business environment surrounding Honda is undergoing significant changes, and the outlook remains uncertain. Previously, with stringent environmental regulations fully implemented in the U.S. and other countries, Honda pursued EV adoption with strong determination that striving for carbon neutrality is a responsibility Honda, as a manufacture of mobility products, must fulfill for the future. However, in the U.S., the expansion of the EV market has slowed down due to several factors including the easing of fossil fuel regulations and revisions to EV incentives.Moreover, in China, what customers value more in automobiles is shifting from hardware features, such as fuel efficiency and cabin space, to software-based features that will continuously advance according to customer preferences. This has intensified the competition due to the rapid emergence of newer EV manufacturers that leverage their short product development cycles and strengths in the area of software-defined vehicle (SDV) technologies, including advanced driver-assistance systems (ADAS). In such a difficult competitive environment, Honda was unable to deliver products that offer value for money better than that of newer EV manufacturers, resulting in a decline in competitiveness.Honda automobile business has fallen into an extremely challenging earnings situation due to various factors, including its inability to respond flexibly to these changes in the business environment, compounded by a decline in the profitability of gasoline and hybrid models due to the impact of newly imposed tariffs.Incurring losses associated with reassessment of automobile electrification strategyIn order to improve the current earnings situation as early as possible, Honda considered various options; however, after careful consideration, the company made the decision to cancel the development and market launch of three EV models that had been planned for production in the U.S., namely the Honda 0 SUV, Honda 0 Saloon, and Acura RSX. Honda determined that starting production and sales of these three models in current business environment where the demand for EVs is declining significantly would likely result in further losses over the long term.Based on this decision, Honda now expects to record 1) write-off and impairment losses on tangible and intangible assets that were intended to be used for the production of these three EV models, as well as 2) losses related to additional expenses resulting from the cancellation of the development and sales of these models.In addition, in consideration of the intensification of competition in China, Honda reassessed the recoverability of investments accounted for using the equity method in China, and now expects to incur an impairment loss on the investments accounted for using the equity method.As a result, in the consolidated financial results for the current fiscal year, Honda expects to record 1) operating expenses of 820 billion yen to 1.12 trillion yen and 2) a share of the loss of investments accounted for using the equity method of 110 billion yen to 150 billion yen. Moreover, Honda expects to record special losses of 340 billion to 570 billion yen in the non-consolidated financial results for the same fiscal year.These amounts are preliminary estimates as of today (March 12, 2026), and should be finalized in the consolidated and non-consolidated financial results for the fiscal year ending March 31, 2026.Furthermore, in the next fiscal year or later, additional expenses or losses may be incurred in connection with the above-mentioned reassessment of the automobile electrification strategy. Combined with the losses to be recorded in the current fiscal year, the total amount of losses is expected to be a maximum of 2.5 trillion yen. This amount is estimated based on information currently available to Honda, and as this estimate includes risks and uncertainties, the actual amount to be recorded may differ from this estimate.In order to achieve more stable and continuous dividends, Honda adopted DOE (dividend on equity ratio) as its shareholder redistribution indicator; therefore, despite this revision to the consolidated financial results for the fiscal year ending March 31, 2026, Honda made no revision to the forecast for the dividend per share for this fiscal year.Future direction for automobile business transformationIn order to respond flexibly to rapid changes in its business environment, Honda is making progress in reorganizing its strategic framework and reestablishing its competitive strengths.In light of the recent slowdown in the growth of the EV market in the U.S., Honda will reassess its resource allocations and further strengthen its hybrid models. As for regional business, in addition to its main markets, namely Japan and the U.S., Honda will enhance the model lineup and cost competitiveness in India, where market expansion is expected. In other countries in Asia as well, Honda will strive to enhance its competitiveness by introducing next-generation hybrid models and reassessing the allocation of its resources.Moreover, in order to strengthen its business structure, Honda will establish a fixed-cost structure appropriate for the scale. Initiatives toward the future introduction of EV models will be implemented flexibly from a long-term perspective, while monitoring the balance between profitability and market trends.Although there is a possibility that additional expenses and/or losses will be recorded in the next fiscal year or later, Honda will maintain stable returns to shareholders by 1) improving profitability of its automobile business with the enhancement of the lineup, including next-generation hybrid models, and 2) leveraging solid earnings power and the cash-generating capability of its motorcycle and financial services businesses.Honda is planning to announce details of the reestablishment of its mid- to long-term strategy for its automobile business at a press conference to be held in May this year. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, March 12, 2026 - (JCN Newswire via SeaPRwire.com) – Japantastics, Inc. has announced the launch of a new collection featuring Kodaimoji artworks by Kei Sato, a Japanese calligrapher and contemporary artist who reimagines ancient Chinese scripts such as oracle bone and bronze inscriptions as modern expressions of art. These early forms of writing, dating back more than 3,000 years, are recognised as the origins of modern Chinese characters and as vessels of timeless human emotion and spirituality.Guided by the concept "Bringing Ancient Characters into Modern Spaces," Sato transforms these primordial symbols into living works that resonate with contemporary aesthetic sensibilities. Her art transcends traditional calligraphy, appearing in diverse media such as wood, metal, ceramics, and stone. By merging historical depth with modern design, Sato creates works that channel the spirit of ancient writing into today's architecture, interiors, and art environments.Kei Sato explains: "Ancient characters are the prototypes of the kanji used today. Although they are the oldest form of written language, their rediscovery in 1988 makes them both ancient and new. Inspired by oracle bone and bronze inscriptions, born from cultures that reflect unchanging human emotions across time, I continue to create under the theme 'Bringing Ancient Characters into Modern Spaces,' hoping to share their essence across all environments.""Child""Happiness"Through her creative practice, Sato seeks not only to preserve these scripts as historical artefacts but to reinterpret and revitalise them, awakening the fundamental beauty and meaning of written forms within the context of contemporary art and space."Sun""Spring"The Japantastics.jp online site now features a selection of Sato's works, which serve as a cultural bridge, reviving the rhythm and beauty of the world's earliest scripts for the modern era. Through her reinterpretations, the primitive strokes once carved into bone or cast in bronze are reborn as expressions of universal harmony, emotion, and timeless design.Kei Sato's major overseas activities:1970: Began practising ancient Chinese calligraphy.1994: Became independent.1997: Established Raira Studio. Developed an original technique of expressing letters with granite in its original stone colour, and presented a lithograph. Held an exhibition at Nagoya Gallery 141, themed “Taking ancient Chinese Calligraphy into modern times”. Her works were exhibited at the Jiangsu Golden Mausoleum Restaurant in Nanjing, China.1999: Her works were exhibited in the Beijing China Museum of History International Calligraphy Exhibition. Held an exhibition at the gallery in Hakuseki Museum in Gifu Pref.2000: Her works were exhibited in the Jiangsu Provincial Art Museum International Calligraphy Exhibitions, Jiangsu, China. Held an exhibition at Nihonbashi Gallery “Kai” in Tokyo, Japan.2006: Her works were exhibited at Melbourne Art Show ’06, Australia. Her works were exhibited at Collingwood Gallery (Art Collection ’06), Australia.2009: Won China-Japan Peace Prize at Tokyo International Art Exhibitions (Sesion Suginami, Tokyo). Her works were exhibited at the Euro-American “America Arts Exhibitions” in Tennessee, USA.2010: Won “Art Gallery Prize” at Tokyo International Art Exhibitions (Tokyo Metropolitan Arts Museum).2011: Exhibited at the International “Japan – France Exhibition of Contemporary Art”, Aoyama Spiral. Won “Art Gallery First Prize” at the International Art Exhibition, Tokyo Metropolitan Arts Museum. Won the Award of Excellence at the Mexico International Art Exhibition, Mexico. Participated in the 21st Century International Artists Exchange and Exhibition, Seoul. Held an exhibition in Salon d’Automne, Paris (France).2012: Participated in International Art Exhibitions “Spain Art Exhibitions”, Spain. Won “Special Prize” (The Window of Art Prize) at *International Japan–France Exhibition of Contemporary Art”, National Art Centre. Participated in the 21st Century International Artists Exchange and Exhibition, Jilin (China). Held an exhibition in Salon d’Automne, Paris (France).2013: Exhibited at the International “Japan–France Exhibition of Contemporary Art”, The National Art Centre.2014: Exhibition at Kyoto International Hotel, Kyoto. Exhibited at the International “Japan – France Exhibition of Contemporary Art”, The National Art Centre. Held an exhibition in Salon d’Automne, Paris (France). Participated in the 21st Century International Artists Exchange and Exhibition. Won Mayor’s Award, Keelung City (Taiwan).2015: International Arts Exhibition (Belgium – Holland Arts Exhibition), Belgium 45th Anniversary.2016: Participated in the Euro-American 'French Art Prize Exhibition' featuring a special large-scale display of black and white works (Corsica).2018: Participated in the Euro-American 'Spanish Art Prize Exhibition' (Spain). Participated in the Euro-American 'Japan-France Contemporary Art World Exhibition' (The National Art Centre, Tokyo). Participated in the 21st Century Calligraphic and Painting Artists International Exchange Exhibition (Seoul). Exhibited at the Salon d'Automne (Paris, France).2019: Participated in the Euro-American 'Finland Art Prize Exhibition' (Finland). Selected for the Salon d'Automne (Paris, France).2020: Selected for the Salon d'Automne (Paris, France).2021: Participated in the Euro-American 'Japan-France Contemporary Art World Exhibition' (The National Art Centre, Tokyo). Selected for the Salon d'Automne (Paris, France).Read more about the Artist at Kei Sato's website (Jap): https://www.kodaimoji.comAbout JapantasticsJapantastics, Inc. is a Tokyo-based company dedicated to promoting and distributing authentic Japan-made products to global audiences. Through its online platform japantastics.jp, the company connects Japanese artisans and small manufacturers with customers worldwide who value quality, creativity, and cultural authenticity. Visit https://japantastics.jpMedia Contact: Japantastics at japantastics@gmail.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 12, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it is launching an initiative to raise public awareness of the importance of sleep in collaboration with the smartphone application “Pokémon Sleep”.It is estimated that 12.4 million adults in Japan—equivalent to 11.8% of the adult population—experience insomnia and the resulting daytime functional impairments.1 According to the 2023 National Health and Nutrition Survey by the Ministry of Health, Labour and Welfare, the percentage of people aged 20 and older who feel they have sufficient rest through sleep has shown a gradual decline, highlighting a consistent downward trend for over a decade.2 The proportion of people who sleep less than six hours per night has also reached 38.5% among men and 43.6% among women.2The feeling of insufficient rest has been linked to decreased daytime performance and an increased risk of lifestyle-related diseases, and securing adequate sleep in terms of both quality and quantity is essential for health promotion and maintenance across all age groups.3 Accordingly, the importance of educational activities aimed at disseminating accurate sleep knowledge is increasing.This initiative is part of Eisai’s efforts to build an ecosystem in the sleep field, a key focus area for the company. By leveraging Eisai’s scientific expertise in sleep and the ability of “Pokémon Sleep” to “inspire action through fun”, the collaboration aims to create opportunities for all generations to reflect on their own sleep and daytime performance, and subsequently raise awareness of the importance of healthy sleep.As the first step of this collaborative awareness initiative, Eisai will provide the picture book “Snorlax’s Dream” to medical institutions across Japan that are actively involved in sleep disorder consultation, primarily to those registered with “Sleep Consultation Navigator” information site powered by Eisai. The story is set in the world of “Pokémon Sleep”. Through an adventure in search of Snorlax, the Pokémon characters convey the “importance of getting sufficient sleep and staying healthy” and “tips for a good sleep” in an entertaining way to readers of all ages. By making the picture book available in the waiting areas of medical institutions, the initiative aims to encourage patients to reflect on their own sleep habits in an environment where they are more likely to be considering their physical condition and lifestyle. Additionally, under the collaboration with Pokémon Sleep, Eisai plans to expand its awareness activities by updating patient education leaflets and creating video content that promotes healthy sleep habits.(Please note that all materials provided are intended for distribution to medical institutions in Japan.)Eisai aims to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities not only through the development of therapeutic drugs, but also by building an ecosystem in collaboration with other industries. Together with “Pokémon Sleep,” Eisai will continue to create an environment where people of different generations can reflect on their sleep habits and achieve positive behavioral changes toward a healthy lifestyle. Through these efforts, Eisai will further contribute not only to individuals living with insomnia and their families but also to those who have concerns about their sleep.Media Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120About “Pokémon Sleep”Pokémon Sleep, the sleep tracker app that turns sleep into entertainment, can be downloaded for free on the Apple App Store or Google Play Store. Learn more about Pokémon Sleep at PokemonSleep.net.[Product Information]Title: Pokémon SleepMSRP: Free to play *Features in-app purchasesPublisher: The Pokémon CompanyDeveloper: SELECT BUTTON Inc.Platforms: iOS/AndroidGenre: SimulationMode: Single-playerSupported languages: Japanese, English, Spanish, French, German, Italian, Korean, Traditional Chinese *The "Spanish" supported by this software is European Spanish.[Official website] https://www.pokemonsleep.net/en/[App store] https://app.adjust.com/1xkxcsv1[Copyright]©Pokémon/Nintendo/Creatures/GAME FREAKPokémon Sleep is developed by SELECT BUTTON inc.TM, ®, and character names are trademarks of Nintendo.The Pokémon Company was established to manage the Pokémon brand. Currently, the company develops and produces video games, which is where Pokémon originates, as well as trading card games, animated TV series and movies, merchandise, tie-up promotions, events, and the Pokémon Center, directly managed Pokémon shops.About the Sleep Information Website Operated by Eisai Eisai provides basic knowledge about sleep and insomnia, self-checks for sleep, information about treatments and medications for insomnia, through "Sodan.e-Nemuri". Additionally, the website offers a wide range of content about sleep for those struggling with sleep issues, including the "Sleep Consultation Navigator" which helps users search for medical institutions that can provide advice and treatments for sleep disorders and insomnia. Please see https://e-nemuri.eisai.jp/ for details. (Japanese only)References1. Clinical Guideline for the Management and Treatment of Sleep Disorders, 3rd Edition (Japanese only)2. The 2023 National Health and Nutrition Survey by the Ministry of Health, Labour and Welfare (Japanese only) https://www.mhlw.go.jp/content/10900000/001338334.pdf3. Sleep Guide for Health Promotion 2023 - Ministry of Health, Labour and Welfare (Japanese only) https://www.mhlw.go.jp/content/001305530. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 12, 2026 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed a first-of-its-kind physical AI (*1) that proactively controls robots to help reduce human stress. This technology utilizes a proprietary "world model" (*2) from NEC to predict human movement and psychological states, quantitatively estimating a person's level of stress.The technology was developed based on a world model, an AI system that is attracting attention globally for accelerating robot adoption. It anticipates the direction a person will move based on the relative position and posture between a robot and the person, predicting the person's level of stress in real time. This enables robots to be controlled along paths and at speeds that reduce human stress.In collaborative human-robot work environments, this reduction of psychological stress can be closely linked to physical safety, helping to avoid collisions and unexpected contact. As a result, expectations are growing for robots utilizing physical AI as a solution to labor shortages and hazardous tasks.However, it is not easy for robots to control their movements based on expected human movements and psychological states. Moreover, robot behavior may cause humans to feel uneasy or tense, potentially hindering smooth collaboration.NEC developed this technology to address these challenges. The technology promotes robot deployment in environments where dedicated robot zones are not yet established, such as small-to-medium-sized logistics warehouses, factories, and retail stores with narrow aisles—locations where stress-related barriers to robot use are conventionally high.This development was achieved by integrating the knowledge and expertise NEC previously accumulated through the research and development of globally recognized models in the field of Physical AI and robot control technologies.The proprietary world model utilized by this technology was developed by combining two prediction models. This has enabled robots to predict the future level of human stress when executing a specific driving control, thereby achieving optimal driving control that anticipates human movement. As a result, it can navigate at speeds and along paths that minimize human stress while maintaining mobility efficiency and suppressing unnecessary deceleration or stops, which can contribute to resolving labor shortages and improving productivity.1. Predicting human movement that changes based on robot behavior and physical surroundingsBy understanding the relationship between "human and robot behavior" as well as "humans and their physical surroundings," NEC has developed a unique prediction model capable of forecasting changing human movement. Using camera footage from robots and their control data, the model can predict with high accuracy the future 3D position and posture of people visible in current footage. This is accomplished in consideration of a robot's behavior and surrounding environmental information.2. Real-time, quantitative estimation of the degree of human stress in relation to a robot’s positionThrough the operation of robots and training AI with experimental results from stress surveys and robot movement data, NEC developed a unique predictive model that quantitatively estimates human stress levels based on the position, posture, and speed among humans and robots. This model enables real-time estimation of stress levels felt by individuals as robots approach them, tailored to each specific situation.Going forward, NEC will continue contributing to the creation of environments where humans and robots can collaborate safely through the implementation of Physical AI.(1) The amount of carbon dioxide absorbed and emitted between forests and the atmosphere.(2) Source: Verra, a nonprofit organization that operates standards in environmental and social markets. "VCS VM0012 Improved Forest Management in Temperate and Boreal Forests (LtPF)."About NECThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society. For more information, please visit https://www.nec.com, and follow us on LinkedIn and YouTube. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

The University of Tokyo’s carbon cycle assessment model, VISIT, and NEC’s data assimilation technology calculate decarbonization effect in forests with greater efficiency and accuracy than conventional methodsTOKYO, Mar 12, 2026 - (JCN Newswire via SeaPRwire.com) - The University of Tokyo’s Graduate School of Agricultural and Life Sciences, Faculty of Agriculture, and NEC have calculated carbon accumulation rates for Lambir Hills National Park in Malaysia based on observed removals data for greenhouse gases (GHG) utilizing the university’s VISIT (Vegetation Integrated SImulator for Trace gases) terrestrial ecosystem model.NEC’s data assimilation technology (patent pending) was used to correct data errors, and observed data was compared with simulated data in order to calculate carbon accumulation rates with a high degree of accuracy, achieving a daily margin of error of 9.4%.BackgroundNEC is promoting initiatives to quantify GHG removals in forests across Southeast Asia and to develop carbon credits in the forest sector. As part of these efforts, NEC has been conducting joint research with the Graduate School of Agricultural and Life Sciences at The University of Tokyo, which developed the VISIT model, an ecosystem model with strengths estimating carbon stocks and fluxes (*1) in forests in the Asian region.The VISIT model estimates carbon stocks and fluxes based on forest vegetation, soil, and meteorological data. By combining VISIT with NEC’s data assimilation technology, exceptionally high-precision estimation of forest carbon accumulation rates has become possible.Data assimilation technology is a computational method that improves model accuracy by adjusting model parameters based on differences between model outputs and observed data. NEC’s data assimilation technology is designed to enhance the accuracy of carbon flux estimations for the future by linking VISIT with image data obtained from satellite-mounted sensors. A patent application has been filed by NEC for this technology.Key features of the VISIT modelThe VISIT model assesses carbon cycles in terrestrial ecosystems. In addition to enabling estimation of carbon stocks and fluxes using vegetation, soil, and meteorological data, the model can also assess the impacts of land-use changes and climate change. VISIT is particularly well suited for improving accuracy based on observed data and is regarded as highly reliable compared with other similar models.Furthermore, the VISIT model is applicable to forests across Asia, including Japan. The methodologies recommended by the Verified Carbon Standard (VCS), the world’s largest voluntary carbon crediting program, primarily reference models developed for Europe and North America and have not specified models tailored to Asian regions (*2). This joint research utilizing the VISIT model is expected to make important contributions to the advancement of forest carbon credit development in Asia.Key features of data assimilationData assimilation is a computational method that improves the accuracy of model estimation by correcting model parameters based on differences between model outputs and observed data. The NEC data assimilation technology used in this joint research has the potential, in the future, to enhance the accuracy of carbon flux estimation by linking the VISIT model with satellite-mounted hyperspectral sensors. A patent application has been filed by NEC for this technology.Currently, the application of data assimilation technology to observational models in the forestry field is not widespread. By applying this technology to the VISIT model, more efficient and highly accurate data collection in forest environments becomes possible, contributing to the advancement of forest conservation initiatives.Building on the findings obtained through this joint research, NEC will accelerate its initiatives in natural capital accounting and carbon credit development.(1) The amount of carbon dioxide absorbed and emitted between forests and the atmosphere.(2) Source: Verra, a nonprofit organization that operates standards in environmental and social markets. About NECThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.For more information, please visit https://www.nec.com, Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

HONG KONG, March 11, 2026 - (ACN Newswire via SeaPRwire.com) – March 9, Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the issuance of the first prescription at The First Affiliated Hospital of Sun Yat-sen University, marking a milestone in patient access in the region. According to reports, on the day the first prescription was issued in mainland China, VELSIPITY(R) was simultaneously prescribed in eight tertiary hospitals across seven key cities—Guangzhou, Shanghai, Hangzhou, Xi’an, Chongqing, Beijing, and Nanjing—achieving immediate coverage of patients in major regions nationwide on its launch day. The drug has also expanded patient access through internet hospital platforms. To date, patients at leading medical institutions, including the First Affiliated Hospital of Sun Yat-sen University, Sir Run Run Shaw Hospital, the First Affiliated Hospital of the Air Force Medical University of the People's Liberation Army, Chongqing People’s Hospital, and Peking Union Medical College Hospital, have already benefited from the therapy.Notably, VELSIPITY(R) was approved for marketing by China’s National Medical Products Administration (NMPA) in February this year. The first prescription in mainland China was issued just one month later, marking a rollout significantly faster than the industry average. Industry observers believe this not only reflects the strong clinical demand for the product but also demonstrates Everest Medicines’ execution capabilities in the commercialization of innovative drugs.From a disease burden perspective, inflammatory bowel disease (IBD) is considered one of the fastest-growing gastrointestinal diseases worldwide. IBD mainly includes ulcerative colitis (UC) and Crohn’s disease (CD). In recent years, the number of patients in China has continued to increase, driven by changes in dietary patterns, shifts in lifestyle, and improvements in diagnostic capabilities. Several industry research institutions predict that China’s IBD treatment market could exceed RMB 10 billion by around 2030, with novel small-molecule innovative drugs expected to become one of the key drivers of market growth.From a clinical perspective, ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease characterized by symptoms such as mucus and blood in the stool, abdominal pain, diarrhea, and rectal tenesmus, which can significantly affect patients’ quality of life. In China, both the incidence and prevalence of UC are increasing, with a clear trend toward younger patients. The patient population is projected to grow from approximately 0.98 million in 2025 to about 1.50 million by 2031. As the disease remains incurable, patients require long-term management to maintain disease control.VELSIPITY(R) is a next-generation, highly selective S1P receptor modulator with best-in-disease potential and strong first-line treatment recommendations for moderately to severely active ulcerative colitis (UC) in both the American Gastroenterological Association (AGA) Clinical Practice Guideline and the American College of Gastroenterology (ACG) Clinical Guideline Update.Results from multiple global clinical studies have demonstrated that VELSIPITY(R) delivers meaningful clinical benefits, including rapid onset of action, long-lasting clinical remission, steroid-free remission, and deep mucosal healing, with a favorable safety profile. In the ENLIGHT UC study, the largest Asian multicenter Phase 3 clinical study, the clinical remission rate at week 40 of the maintenance period reached 48.1%, and the deep mucosal healing rate reached 51.9%, with an endoscopic mucosal normalization rate of 45.5%. These findings demonstrate VELSIPITY(R)'s potential to improve long-term disease outcomes and reduce the risk of relapse and disease progression.Results from the ELEVATE UC open-label extension demonstrate continuous treatment with VELSIPITY(R) for up to 3 years resulted in 86.8% of patients achieving a clinical response among the observed cases, with both clinical remission and mucosal healing rates maintained at approximately 60%. Safety data extending up to five years from the global clinical program further confirm that VELSIPITY(R) is well tolerated and maintains a favorable and stable safety profile.Prof. Chen Minhu, Academic Leader of the Department of Gastroenterology at The First Affiliated Hospital of Sun Yat-sen University, noted that with the first prescription now issued, VELSIPITY(R) is being incorporated into routine clinical practice, providing physicians with an innovative treatment option for patients living with UC who continue to face ongoing disease challenges.“Early achievement of mucosal healing is recognized as a key treatment goal, as it can significantly reduce rates of disease relapse, hospitalization, surgery, and the risk of progression to colorectal cancer. VELSIPITY(R) addresses this need by targeting intestinal inflammation at its source and promoting mucosal healing, while offering a favorable profile of efficacy and safety, along with the convenience of an oral, once-daily regimen, supporting sustained disease management and improving patients' quality of life,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.In 2024 and 2025, VELSIPITY(R) was included in the Catalogues of Guangdong Province on Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in Nine Mainland Municipalities of the Guangdong-Hong Kong-Macao Greater Bay Area, making it available at designated hospitals across the region. Real-world data have shown that the efficacy and safety of VELSIPITY(R) are consistent with those observed in clinical trials.From a commercialization perspective, Everest Medicines has already demonstrated a mature and replicable capabilities through its core nephrology product NEFECON(R). As the world’s first and currently the only etiological treatment for IgA nephropathy (IgAN) to receive full approvals in China, the United States, and Europe, Nefecon(R) generated more than RMB 1 billion in sales in the first three quarters of 2025. The product has set a new benchmark for non-oncology therapies and has become one of the best-performing chronic disease drugs added to China’s national reimbursement list over the past decade.This achievement has validated the company’s platform for the commercialization of innovative medicines, centered on the integrated coordination of access, medical, marketing, and sales (A2MS) driven by scientific and commercial insights. It has also provided replicable systems and experience for the market expansion of future products. The rapid issuance of the first prescription for VELSIPITY(R) further demonstrates the efficiency of this platform. Leveraging the channel network and market access experience built through Nefecon(R), the product is expected to replicate a similar growth trajectory.From a market landscape perspective, China’s UC treatment market has long been dominated by traditional immunosuppressants and injectable biologics. However, these therapies present certain limitations, including lack of oral convenience and potential long-term safety risks. With its differentiated advantages, VELSIPITY(R) is widely viewed by the industry as having the potential to address this unmet need. Market expectations suggest that the drug could reach peak sales of RMB 5 billion, becoming a key driver of revenue growth for Everest Medicines.Everest Medicines stated that it plans to build a multi-channel market access framework, provide diversified patient assistance programs and innovative payment solutions, and actively pursue the inclusion of VELSIPITY(R) in China’s National Reimbursement Drug List (NRDL) to improve the drug’s accessibility and affordability. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TOKYO, Mar 11, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today the company will present the latest findings on lecanemab (generic name, U.S. brand name: LEQEMBI®), Eisai’s anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease (AD), at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD™ 2026) from March 17-21, in Copenhagen, Denmark, and online. The lecanemab data and additional research findings from Eisai’s AD portfolio will be featured in six presentations, including three oral presentations. Eisai will host an industry-sponsored symposium.Oral and Poster PresentationsOral presentations will include the latest findings from a United States real-world long-term treatment persistence study, and efficacy and safety outcomes in apolipoprotein E ε4 (ApoEε4) homozygous carriers in a U.S. multicenter real-world study. In addition, four-year data from the Clarity AD Open-Label Extension trial in ApoEε4 non-carriers and heterozygotes, and a genome-wide association study on novel genetic variants associated with cognitive decline in AD will be presented as posters.Eisai Symposium – Continue Life Their Way: Early Intervention in Alzheimer’s DiseaseEisai is sponsoring a symposium featuring four leading global experts in the field of AD, on the topics of why early intervention matters, continuing early AD treatment and real-world outcomes. The symposium aims to enhance understanding of the value of early and continued anti-amyloid treatment in early AD by exploring how real-world evidence can support confident patient assessment in clinical practice, and how to recognize AD as a chronic condition that requires a multidisciplinary approach to care.Eisai serves as the lead of lecanemab development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.AD/PD 2026 Presentations Relating to Eisai's Key Compounds and ResearchFor more information, please visit: https://www.eisai.com/news/2026/pdf/enews202612pdf.pdfMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120Eisai Europe, Ltd.(Europe, Australia, New Zealand and Russia)EMEA Communications Department+44 (0) 7739-600-678EMEA-comms@eisai.netEisai, Inc. (U.S.)Julie Edelman+1-862-213-5915Julie Edelman@eisai.comAbout Lecanemab (generic name, brand name: Leqembi)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in 53 countries and regions including Japan, the United States, China, Europe, South Korea, Taiwan, and Saudi Arabia, and is under regulatory review in 6 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks was approved in 7 countries including the U.S., China, the UK, and others, and applications have been filed in 10 countries and regions. The U.S. FDA approved Eisai’s Biologics License Application (BLA) for subcutaneous maintenance dosing with LEQEMBI IQLIK in August 2025. A Supplemental Biologics License Application (sBLA) for initiation treatment was accepted in January 2026. The sBLA has been granted Priority Review, with a Prescription Drug User Fee Act (PDUFA) action date of May 24, 2026. In November 2025, an application for a subcutaneous injectable formulation in Japan was submitted. In January 2026, the Biologics License Application (BLA) for the subcutaneous formulation was accepted in China. In December 2025, Lecanemab (IV) has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About ProtofibrilsProtofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of soluble Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition.¹ Protofibrils cause injury to neurons in the brain, which in turn, can negatively impact cognitive function via multiple mechanisms, not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may prevent the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.²About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with both companies cocommercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.References1. Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12: 3451. doi:10.1038/s41467-021-23507-z.2. Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com